Evaluation of Clinical Outcomes, Tolerability, and Costs of Avelumab Maintenance and Pembrolizumab Second-Line Therapy in Advanced Urothelial Cancer.
Clinical trial NCT07207928 · COMPLETED
Trial details
- NCT number
- NCT07207928
- Sponsor
- Azienda Ospedaliera Universitaria Integrata Verona
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-09-16
- Primary completion
- 2025-02-21
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.